SCHEMBL12650386

SCHEMBL12650386

C=C(C)O[C@H](C(=O)OC)c1c(C)nc2c(cnn2Cc2ccc(OC)cc2)c1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE1A P54750 4/20 0.41
▸ PDE1B Q01064 4/20 0.41
▸ PDE1C Q14123 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CNR2 P34972 2/20 0.38
▸ UCHL1 P09936 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE9A O76083 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ RAF1 P04049 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ NPBWR1 P48145 2/20 0.36
▸ MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12604336 0.88 CNR2 (0.41) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604357 0.88 CNR2 (0.41) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604354 0.86 PDE1A (0.44) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604341 0.81 CNR2 (0.42) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604409 0.79 CACNA1H (0.37) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604342 0.75 PDE1A (0.42) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604333 0.74 PDE1A (0.48) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604347 0.72 NR3C1 (0.39) ALDH1A1HPGDNPSR1HSD17B10GAA
SCHEMBL12604334 0.71 UCHL1 (0.51) PDE1APDE1BPDE1CALDH1A1LMNA
SCHEMBL12604349 0.71 UCHL1 (0.51) PDE1APDE1BPDE1CALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118249-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) 2011-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118249-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION RTF2, CCNY, RTF1 PDE1A 4666/4885PDE1B 4698/4885PDE1C 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback